We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+4.44%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.49B
AUM Growth
+$60.2M
Cap. Flow
+$11.8M
Cap. Flow %
0.79%
Top 10 Hldgs %
38.05%
Holding
161
New
4
Increased
69
Reduced
20
Closed
5

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$10.9M
2
KLAC icon
KLA
KLAC
+$3.03M
3
WDC icon
Western Digital
WDC
+$2.92M
4
CHKP icon
Check Point Software Technologies
CHKP
+$2.49M
5
AAPL icon
Apple
AAPL
+$1.63M

Top Sells

Rank Stock Value
1
CSRA
CSRA Inc.
CSRA
+$13.6M
2
JPM icon
JPMorgan Chase
JPM
+$9.98M
3
AZN icon
AstraZeneca
AZN
+$1.22M
4
BDX icon
Becton Dickinson
BDX
+$1.19M
5
GLW icon
Corning
GLW
+$1.13M

Sector Composition

Rank Sector Weight
1 Technology 36.4%
2 Financials 16.86%
3 Communication Services 15.69%
4 Healthcare 12.35%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
101
CVS Health
CVS
$137B
$1.22M 0.08%
18,900
– –
PANW icon
102
Palo Alto Networks
PANW
$264B
$1.21M 0.08%
35,400
– –
NXGN
103
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.15M 0.08%
58,700
– –
IQ icon
104
iQIYI
IQ
$1.18B
$1.11M 0.07%
34,305
-7,855
-19% -$191K
NTES icon
105
NetEase
NTES
$76.5B
$1.09M 0.07%
21,525
– –
KEM
106
DELISTED
KEMET Corporation
KEM
$1.08M 0.07%
44,595
– –
SYK icon
107
Stryker
SYK
$127B
$1.02M 0.07%
6,060
-1,700
-22% -$286K
MDT icon
108
Medtronic
MDT
$107B
$958K 0.06%
11,196
-4,846
-30% -$405K
NVO
109
Novo Nordisk
NVO
$216B
$935K 0.06%
40,560
-440
-1% -$10.5K
AMBA icon
110
Ambarella
AMBA
$2.99B
$929K 0.06%
24,070
– –
SAM icon
111
Boston Beer
SAM
$1.88B
$833K 0.06%
2,780
– –
MA icon
112
Mastercard
MA
$477B
$813K 0.05%
4,139
– –
PRFT
113
DELISTED
Perficient Inc
PRFT
$769K 0.05%
29,165
– –
SEDG icon
114
SolarEdge
SEDG
$2.59B
$701K 0.05%
14,640
+225
+2% +$12.5K
MERC icon
115
Mercer International
MERC
$44.9M
$676K 0.05%
38,640
-7,695
-17% -$116K
CSGS
116
DELISTED
CSG Systems International
CSGS
$664K 0.04%
16,255
– –
KLIC icon
117
Kulicke & Soffa
KLIC
$5.3B
$663K 0.04%
27,845
– –
MGLN
118
DELISTED
Magellan Health Services, Inc.
MGLN
$661K 0.04%
6,885
– –
EGRX
119
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$622K 0.04%
8,220
– –
CVSA
120
Covista Inc
CVSA
$3.94B
$619K 0.04%
12,875
– –
PRSP
121
DELISTED
Perspecta Inc. Common Stock
PRSP
$592K 0.04%
+28,830
New +$646K
AUB icon
122
Atlantic Union Bankshares
AUB
$5.99B
$590K 0.04%
15,185
– –
NOV icon
123
NOV
NOV
$7.45B
$570K 0.04%
13,125
+6,530
+99% +$264K
AAN.A
124
DELISTED
The Aaron's Company Inc Class A
AAN.A
$569K 0.04%
13,090
– –
NFLX icon
125
Netflix
NFLX
$292B
$556K 0.04%
14,200
– –
3 4
5
6 7

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Oak Associates held 161 positions worth $1.49B, up 4.2% from $1.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Oak Associates's Q2 2018 filing shows 4 new, 69 increased, 20 reduced and 5 closed positions. Its largest new stake was Perspecta Inc. Common Stock: 28,830 shares worth $592K. The largest sale was CSRA Inc., an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Financials and Communication Services.

  • Oak Associates's largest Q2 2018 buy was Perspecta Inc. Common Stock: 28,830 shares worth $592K.
  • Oak Associates added most to Novartis in Q2 2018, an estimated $10.9M increase.
  • Oak Associates's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $9.98M.
  • Oak Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $13.6M.
  • Oak Associates's ten largest holdings make up 38% of its $1.49B portfolio in Q2 2018.
  • Oak Associates opened 4 new positions and closed 5 in Q2 2018.
  • Oak Associates's portfolio value rose 4.2% quarter-over-quarter to $1.49B.

Based on Oak Associates's 13F filing for Q2 2018, filed 14 Aug 2018.